logo-loader
Motif Bio PLC

Motif Bio assessing lead drug iclaprim potential as a combatant for the life-threatening infection listeria

Partner JMI Laboratories will use pre-clinical services provided by National Institute of Allergy and Infectious Diseases, to assess the antibiotic

Motif Bio PLC -

Motif Bio PLC (LON:MTFB) is assessing the potential of lead drug iclaprim as a combatant for the life-threatening infection listeria.

Partner JMI Laboratories will use pre-clinical services provided by National Institute of Allergy and Infectious Diseases, to assess the antibiotic.

It follows earlier lab testing in which iclaprim was shown to be more than 32-times more potent than ampicillin, the current standard of care.

“If the results of this study confirm that iclaprim has potent activity against L. monocytogenes, we believe that iclaprim could be a potentially useful treatment option and would warrant further study," said David Huang, Motif’s chief medical officer.

While rare, listeria causes around 1,600 deaths in the US. It can cause septicaemia or meningitis, and about 260 people die from it.

Quick facts: Motif Bio PLC

Price: £0.02

Market: AIM
Market Cap: £8.15 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Motif Bio PLC named herein, including the promotion by the Company of Motif Bio PLC in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: AfriTin Mining produces first concentrate from Uis mine

Headlines from the Proactive UK newsroom. AfriTin Mining (LON:ATM) has produced is first tin concentrate from the Uis mine in Namibia. The miner has also signed an offtake deal with a Thai group.  BlueRock Diamonds (LON:BRD) has sold a fifth diamond this year for more than US$50,000....

on 19/8/19

2 min read